SARS-CoV-2 epidemics raises a considerable issue of public health at the planetary scale.
There is a pressing urgency to find treatments based upon currently available scientific
knowledge. Therefore, we tentatively propose a hypothesis which hopefully might ultimately
help save lives. Based on the current scientific literature and on new epidemiological data
which reveal that current smoking status appears to be a protective factor against the
infection by SARS-CoV-2 [1], we hypothesize that the nicotinic acetylcholine receptor …